EQS-Adhoc 533 0 Kommentare LifeWatch AG: Verwaltungsrat von LifeWatch empfiehlt verbesserte Offerte von BioTelemetry zur Annahme - Seite 4

It may be difficult for U.S. holders to enforce their rights and any claim arising out of U.S. federal securities laws, since LifeWatch is located in a non-U.S. jurisdiction, and some or all of its officers and directors may be residents of a non-U.S. jurisdiction. U.S. holders may not be able to sue a non-U.S. company or its officers or directors in a non-U.S. court for violations of the U.S. securities laws. Further, it may be difficult to compel a non-U.S. company and its affiliates to subject themselves to a U.S. court's judgment.

The receipt of cash and stock consideration in the Offer by a U.S. shareholder will generally be a taxable transaction for U.S. federal, state and local income tax purposes. Each U.S. shareholder is urged to consult his independent professional adviser immediately regarding the tax consequences of acceptance of the Offer.

Securities may not be offered or sold in the U.S. absent registration or an exemption from registration under the U.S. Securities Act. It is expected that the Offer will be subject to a Tier I exemption pursuant to Rule 14d-1(c) of the U.S. Securities Exchange Act of 1934, as amended, and that the issuance of BioTelemetry Common Stock in connection therewith will be exempt from registration under the U.S. Securities Act of 1933, as amended, pursuant to Rule 802 thereof.

Neither the Securities and Exchange Commission nor any securities commission of any State of the U.S. has (a) approved or disapproved of the Offer, (b) passed upon the merits or fairness of the Offer, or (c) passed upon the adequacy or accuracy of the disclosure in the pre-announcement. Any representation to the contrary is a criminal offense in the U.S.

Im Zweifelsfall gilt die englische Originalmeldung.

Zusatzmaterial zur Meldung:

Dokument: http://n.eqs.com/c/fncls.ssp?u=UMVKLMFCTQ
Dokumenttitel: Bericht des Verwaltungsrats von LifeWatch

Ende der Ad-hoc-Mitteilung

Sprache:	Deutsch
Unternehmen:	LifeWatch AG
	Baarerstrasse 139
	6300 Zug
	Schweiz
Telefon:	+41 41 728 67 78
Internet:	www.lifewatch.com
ISIN:	CH0012815459
Valorennummer:	811189
Börsen:	Freiverkehr in Berlin, Stuttgart; Open Market in Frankfurt; SIX Swiss Exchange